Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03633162

Maternal Grandmothers in the Born in Guangzhou Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Guangzhou Women and Children's Medical Center · Academic / Other
Sex
Female
Age
36 Years – 100 Years
Healthy volunteers
Accepted

Summary

The MGBIG is a study exploring cross-generational effects in 5000 women and their children and grandchildren located in Guangzhou, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology and on explaining the cause of the disease from the perspective of "grandmother-mother-child" heredity. Data are collected regarding environmental exposures, lifestyle, and social support on grandmother from birth to old age. Biological samples including blood and tissue samples are collected.

Detailed description

It was previously believed that heredity strictly follows Mendel's laws, but recent studies have found that through placental material exchange, mammals may transfer maternal immune-related factors vertically, thus promoting the protection of "non-heredited maternal antigenic traits". Thus, the transmission of reproductive information across generations is realized. Since the unusual genetic pattern of the X chromosome, grandmother's influence may be gender specific. Since grandchildren were usually took care by grandparents in China, it could be achievable to attach and recruit maternal grandmother together with mother and children. Cohort including three generations of women is rare in Asia at present. In the MGBIG, extensive information including demographic characteristics, lifestyle, history of diseases, mental health, and behaviors is collected from the participants. Longitudinal follow up and surveillance of common chronic diseases are also to be conducted. The MGBIG intends to recruit maternal grandmothers to study the effects of maternal genetic and environmental exposure on the health of their children and grandchildren.

Conditions

Interventions

TypeNameDescription
OTHER

Timeline

Start date
2018-05-21
Primary completion
2025-12-31
Completion
2038-12-31
First posted
2018-08-16
Last updated
2024-10-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03633162. Inclusion in this directory is not an endorsement.